CD44 and carcinoma: CD44, a non-kinase cell surface transmembrane glycoprotein, was described in 1989 by Stamenkovic et al., and two main forms of the protein were identified–a lymphoid form present in hematopoietic cells and an epithelial form weakly expressed in normal epithelium and abundantly expressed in carcinomas (Stamenkovic et al., 1989).